Jothydev Kesavadev

Endocrinology — Jothydev's Diabetes and Research Center, India

LeadR Profile

854 ScienceLeadR Reputation 854
Network Map

Endocrinology

Subspecialties: Gastroenterology - Cardiology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2006 - 2026

Source: PubMed

Jothydev's Diabetes and Research Center

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 235

Citations

Citations: 7 180 1st author: 95 Last author: 16 Unique author: 14


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Original rDNA Semaglutide Versus Synthetic Copies: Differences and Clinical Implications.
therapeutics, dna, ribosomal, semaglutide
Cureus20260
Corrigendum to "Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation" [Obesity Pillars 19 (2026) 100296].
obesity, glucagon, therapeutics, glucagon-like peptides
Obes Pillars20260
Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 study.
diabetes mellitus, safety, liver, pioglitazone, therapeutics, glycemic control, diabetes mellitus, type 2
Front Clin Diabetes Healthc20261
Expert Consensus and Physician Perspectives on a Low-dose Triple Fixed-dose Combination for Type 2 Diabetes in India.
diabetes mellitus, safety, physicians, therapeutics, diabetes mellitus, type 2
J Assoc Physicians India20260
Consensus Guidance for the Diagnosis and Management of Diabetic Kidney Disease: Executive Summary.
kidney diseases, diabetic nephropathies, kidney, diagnosis
J Assoc Physicians India20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

N/A 4
Phase 3 4
Phase 4 2

By status:

Completed 9
Recruiting 1

By type:

Interventional 9
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 0
multicentricup10 5

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity Related Complications or Progression to Class 1 Obesity
NCT07794579 — safety, early intervention, educational, prediabetic state, prehypertension, obesity, risk factors, obesity, abdominal, overweight, heart disease risk factors, weight control
Phase 3Recruiting2026

LeadR Networks

Main global connection map